Scinovex
articleTop 1% cited

Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment

Nephrology Dialysis Transplantation · 2002 · Vol. 17(9) · pp. 1684–1688
Roberto Pecoits‐Filho

Abstract

The present study demonstrates that the strong predictive value of elevated IL-6 levels for poor outcome in ESRD patients is similar in both HD and PD patients starting treatment.

Dialysis and Renal Disease ManagementVitamin C and Antioxidants ResearchVitamin D Research StudiesMedicinePeritoneal dialysisInternal medicineDialysisQuartileHemodialysisDiabetes mellitusEnd stage renal diseasePopulationGastroenterology

MeSH terms

FemaleRenal DialysisHumansKidney Failure, ChronicMaleMiddle AgedPeritoneal DialysisPredictive Value of TestsTime FactorsBiomarkersInterleukin-6Survival RateProportional Hazards ModelsTreatment OutcomeReceptors, Interleukin-6

Funding

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
Citations
394
FWCI
12.27
field-weighted impact
References
23
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.